Infusion of Iloprost, a Prostacyclin Analogue, for Treatment of Raynaud's Phenomenon in Systemic Sclerosis.

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.47.1.43
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Prostaglandins I2 and E1 and Red Cell Deformability in Raynaud's Phenomenon and Systemic Sclerosis

BMJ
1981English

Raynaud's Phenomenon

Nurse Prescribing
2017English

Effect of Prostaglandins I2 and E1 on Red Cell Deformability in Patients With Raynaud's Phenomenon and Systemic Sclerosis.

BMJ
1981English

Pulse Cyclophosphamide Decreases Sympathetic Postganglionic Activity, Controls Alveolitis, and Normalizes Vascular Tone Dysfunction (Raynaud's Phenomenon) in a Case of Early Systemic Sclerosis

Arthritis Care & Research
2004English

Neurological Involvement in Systemic Sclerosis. Evidence of a Central Raynaud’s Phenomenon

Reumatismo
Rheumatology
2011English

Raynaud's Phenomenon in Pediatric Age

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2011English

A Woman With Dysphagia and Raynaud's Phenomenon

Postgraduate Medical Journal
Medicine
2002English

Autohaemagglutination and Raynaud's Phenomenon

BMJ
1947English

Assessment and Management of Raynaud's Phenomenon

Prescriber
Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy